Cargando…
Anti-Cancer Effects of an Optimised Combination of Ginsenoside Rg3 Epimers on Triple Negative Breast Cancer Models
Key problems of chemotherapies, as the mainstay of treatment for triple-negative breast cancer (TNBC), are toxicity and development of tumour resistance. Using response surface methodology, we previously optimised the combination of epimers of ginsenoside Rg3 (Rg3) for anti-angiogenic action. Here,...
Autores principales: | Nakhjavani, Maryam, Smith, Eric, Palethorpe, Helen M., Tomita, Yoko, Yeo, Kenny, Price, Tim J., Townsend, Amanda R., Hardingham, Jennifer E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308773/ https://www.ncbi.nlm.nih.gov/pubmed/34208799 http://dx.doi.org/10.3390/ph14070633 |
Ejemplares similares
-
Anti-Angiogenic Properties of Ginsenoside Rg3 Epimers: In Vitro Assessment of Single and Combination Treatments
por: Nakhjavani, Maryam, et al.
Publicado: (2021) -
Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer
por: Nakhjavani, Maryam, et al.
Publicado: (2019) -
Stereoselective Anti-Cancer Activities of Ginsenoside Rg3 on Triple Negative Breast Cancer Cell Models
por: Nakhjavani, Maryam, et al.
Publicado: (2019) -
Anti-Angiogenic Properties of Ginsenoside Rg3
por: Nakhjavani, Maryam, et al.
Publicado: (2020) -
Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer
por: Nakhjavani, Maryam, et al.
Publicado: (2019)